PHARMATHENE, INC

Biotechnology research, development and manufacturing. Biodefense vaccines/therapeutics

Filings
43
Clients
1
Total Income
Years Active
2007–2016

Filings

Year Client Period Income Expenses Doc
2007 PHARMATHENE, INC Year-End (July 1 - Dec 31)
Year-End Report
$300,000
2007 PHARMATHENE, INC Year-End (July 1 - Dec 31)
AMENDED
$180,000

Clients Represented

ClientFilingsTotal Income
PHARMATHENE, INC 43

Lobbyists

NameDisclosed Prior Position
FRANCESCA COOK VP, POLICY & GOVERNMENT AFFAIRS
MARK EDWARD COOKE SR. DIRECTOR, GOVERNMENT AFFAIRS